Sort
16,300 grants matching “fatty liver disease”
Breast Cancer Survivors Cardiovascular Risks: Treatment and Behavioral Influences
$61,481Janice K Kiecolt-Glaser · Ohio State University · R01 · FY2015 · CA
Breast Cancer Survivors Cardiovascular Risks: Treatment and Behavioral Influences
$61,481Janice K Kiecolt-Glaser · Ohio State University · R01 · FY2015 · CA
Breast Cancer Survivors Cardiovascular Risks: Treatment and Behavioral Influences
$61,481Janice K Kiecolt-Glaser · Ohio State University · R01 · FY2017 · CA
Breast Cancer Survivors Cardiovascular Risks: Treatment and Behavioral Influences
$61,481Janice K Kiecolt-Glaser · Ohio State University · R01 · FY2017 · CA
Breast Cancer Survivors Cardiovascular Risks: Treatment and Behavioral Influences
$61,481Janice K Kiecolt-Glaser · Ohio State University · R01 · FY2016 · CA
Breast Cancer Survivors Cardiovascular Risks: Treatment and Behavioral Influences
$61,481Janice K Kiecolt-Glaser · Ohio State University · R01 · FY2016 · CA
Mechanistic Insights into Aryl Hydrocarbon Receptor Regulation of Fibroblast Growth Factor 21 and its Influence on Systemic Energy Metabolism
$61,226Nathaniel Girer · University Of Texas Med Br Galveston · F32 · FY2019 · DK
Abcb11 and Hepatic Transport
$61,202Anne S Henkel · Northwestern University At Chicago · F32 · FY2008 · DK
Energy Sensors and the Regulation of the TCA Cycle in the Liver
$61,174Justin Fletcher · Ut Southwestern Medical Center · F32 · FY2018 · DK
The Role of the Mediator Complex in the Transcriptional Regulation of Lipogenesis
$60,990Jose Abraham Viscarra · University Of California Berkeley · F32 · FY2017 · DK
Role of branched-chain amino catabolism in lymphopoiesis and lymphomagenesis
$60,990Mario R Fernandez · H. Lee Moffitt Cancer Ctr & Res Inst · F32 · FY2017 · CA
Development of Neurosteroids for Lysosomal Storage Disorders
$60,985Asaf Alimardanov · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
Diversity Supplement to Role of Wnt/beta-catenin In Liver Regeneration
$60,839Satdarshan Singh Monga · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DK
Functional characterization of a novel gene for non-alcoholic fatty liver disease
$60,782Alexis L Gorden · University Of Maryland Baltimore · F32 · FY2011 · DK
Hepatic expression of small hairpin RNA using gutless adenoviral vectors
$60,643Nuria Morral · Indiana University Indianapolis · R01 · FY2012 · DK
Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease
$60,538Mark J. Czaja · Albert Einstein College Of Medicine · R01 · FY2015 · DK
MOUSE METABOLIC PHENOTYPING CENTER
$60,487Craig R. Malloy · Ut Southwestern Medical Center · P41 · FY2007 · RR
Osteocyte Regulation of Bone/Muscle with Age
$60,400Lynda F Bonewald · University Of Missouri Kansas City · P01 · FY2014 · AG
Clinical Research Network in Non-Alcoholic Steatohepatitis
$60,279Kris Kowdley · Benaroya Research Inst At Virginia Mason · U01 · FY2013 · DK
The Saint Louis University Component of the NASH Clinical Research Network
$60,217Brent A Neuschwander-Tetri · Saint Louis University · U01 · FY2013 · DK
Functional consequences of plasmalogens - Membrane curvature and lipid miscibility
$60,162Alison Leonard · University Of Delaware · F32 · FY2020 · GM
Multi-Center Group Study of Acute Liver Failure
$60,146Children'S Hospital Med Ctr (Cincinnati) · M01 · FY2004 · RR
Role of Toll-like Receptor-4 in Obesity-associated HCC
$60,128Vanderbilt University · F32 · FY2005 · DK
Preventing Diabetes in Latino Youth
$60,085Gabriel Quantum Shaibi · Arizona State University-Tempe Campus · R01 · FY2018 · DK
Investigating Synthetic Ligands for the Treatment of NASH
$59,970Kristine Griffett · Saint Louis University · F32 · FY2016 · DK